Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear? (Q33819306)

29 July 2017

title

Purpose and benefits of early phase cancer trials: what do oncologists say? What do patients hear? (English)

1 reference

29 July 2017

4

Jeremy Sugarman

1 reference

29 July 2017

1

Nancy Kass

1 reference

29 July 2017

7

Michael Carducci

1 reference

29 July 2017

Holly Taylor

2

1 reference

29 July 2017

Linda Fogarty

3

1 reference

29 July 2017

Steven N Goodman

5

1 reference

29 July 2017

Annallys Goodwin-Landher

6

1 reference

29 July 2017

Herbert Hurwitz

8

1 reference

29 July 2017

publication date

1 September 2008

1 reference

Journal of Empirical Research on Human Research Ethics

29 July 2017

published in

1 reference

29 July 2017

volume

3

1 reference

29 July 2017

issue

3

1 reference

29 July 2017

page(s)

57-68

1 reference

Ethics of phase 1 oncology studies: reexamining the arguments and data

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Quality of informed consent in cancer clinical trials: a cross-sectional survey

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Does how you do depend on how you think you'll do? A systematic review of the evidence for a relation between patients' recovery expectations and health outcomes

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Psychological resources, positive illusions, and health

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Factors that influence a patient's decision to participate in a phase I cancer clinical trial.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Phase I cancer trials. A collusion of misunderstanding.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Impact of quality of life on patient expectations regarding phase I clinical trials.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Attitudes toward clinical trials among patients and the public

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Patient motivation and informed consent in a phase I study of an anticancer agent

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Dispositional optimism and physical well-being: the influence of generalized outcome expectancies on health.

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Patient participation in the patient-provider interaction: the effects of patient question asking on the quality of interaction, satisfaction and compliance

4 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Hope for the best, and prepare for the worst

4 July 2018

1 reference

https://api.crossref.org/works/10.1525%2FJER.2008.3.3.57

Developing ethical strategies to assist oncologists in seeking informed consent to cancer clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1525%2FJER.2008.3.3.57

Perceptions of cancer patients and their physicians involved in phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1525%2FJER.2008.3.3.57

Risks and benefits of phase 1 oncology trials, 1991 through 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1525%2FJER.2008.3.3.57

A need to try everything: patient participation in phase I trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1525%2FJER.2008.3.3.57

Informed consent to biomedical research in Veterans Administration Hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1525%2FJER.2008.3.3.57

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1525%2FJER.2008.3.3.57

Optimism and survival in lung carcinoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1525%2FJER.2008.3.3.57

Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

What patients say about medical research

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Trust, The fragile foundation of contemporary biomedical research

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2861824

Therapeutic response in phase I trials of antineoplastic agents

29 October 2018

1 reference

12 December 2020

How do doctors explain randomised clinical trials to their patients?

1 reference

12 December 2020

Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center

1 reference

12 December 2020

Proposing phase I studies: patients', relatives', nurses' and specialists' perceptions

1 reference

12 December 2020

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

12 December 2020

Effects of outcome framing on treatment decisions in the real world: impact of framing on adjuvant breast cancer decisions

1 reference

12 December 2020

Identifiers

DOI

10.1525/JER.2008.3.3.57

1 reference

29 July 2017

1 reference

29 July 2017

1 reference